MedWatch

Novartis chief sees remote-work hybrid persisting after pandemic

Novartis, the Swiss pharma giant, is rethinking its use of office space as a hybrid of at-home and in-office work extends beyond the pandemic.

Photo: Anthony Anex/AP/Ritzau Scanpix

(Bloomberg) --Novartis, the Swiss pharma giant, is rethinking its use of office space as a hybrid of at-home and in-office work extends beyond the pandemic.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Latest news

See all jobs